RAZI-COV PARS candidate vaccine is different from the previous protein-based vaccines of COVID-19, because it contains three immunogenic components of two subunits, S1 and S2 and trimeric S protein of SARS-CoV-2 together. This evidence concerns the gene PROS1 and COVID-19.